A Euglycemic Insulin Clamp Study in Type 1 Diabetic Patients With Oral Insulin (ORAMED)
Status:
Completed
Trial end date:
2017-04-01
Target enrollment:
Participant gender:
Summary
ORAMED has developed an oral insulin that, in preliminary studies, has shown promise. In the
present study investigators will perform a pharmacodynamic/pharmacokinetic study to evaluate
this novel insulin preparation as a potential therapeutic option in diabetic patients.
Phase:
Phase 2
Details
Lead Sponsor:
The University of Texas Health Science Center at San Antonio